✦ LIBER ✦

Hormonal and metabolic characteristics of geneticall obese Zucker and dietar obese Sprague-Dawle rats

✍ Scribed by ROMANO NOSADINI; FULVIO URSINI; PAOLO TESSARI; MARIA CHIARA GAROTTI; FLORA DE BIASI; ANTONIO TIENGO

Book ID: 114726096
Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 501 KB
Volume: 10
Category: Article
ISSN: 0014-2972
DOI: 10.1111/j.1365-2362.1980.tb02069.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic profiling of livers and blood

Metabolic profiling of livers and blood from obese Zucker rats

✍ Natalie J. Serkova; Matthew Jackman; Jaimi L. Brown; Tao Liu; Ryutaro Hirose; Jo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Metabolic consequences of fasting in old

Metabolic consequences of fasting in old lean and obese Zucker rats

✍ Joseph Triscari; Graeme F. Bryce; Ann C. Sullivan 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 911 KB

The metabolic clearance rate of corticos

The metabolic clearance rate of corticosterone in lean and obese male Zucker rats

✍ B.Douglas White; Constance B. Corll; Johnny R. Porter 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 817 KB

Central and peripheral dysregulation of

Central and peripheral dysregulation of melanin-concentrating hormone in obese Zucker rats

✍ Alain Stricker-Krongrad; Todor Dimitrov; Bernard Beck 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Effect of mevinolin on cholesterol metab

Effect of mevinolin on cholesterol metabolism in obese and lean Zucker rats

✍ Sylvia A. McCune; Richard R. Jurin 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Rimonabant reduces obesity-associated he

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

✍ Magali Gary-Bobo; Ghizlane Elachouri; Jean François Gallas; Philip Janiak; Pietr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB

This study investigated the effects of rimonabant (SR141716), an antagonist of the cannabinoid receptor type 1 (CB1), on obesity-associated hepatic steatosis and related features of metabolic syndrome: inflammation (elevated plasma levels of tumor necrosis factor alpha [TNF␣]), dyslipidemia, and red